Human Genome Research Led To $65 Billion In Economic Output In 2012, Says Battelle Report
This article was originally published in The Gray Sheet
Executive Summary
A Battelle report on the impact of genomics on the U.S. economy found that research on human genome sequencing led to $65 billion in economic output in 2012, and contributed $31 billion toward the 2012 gross domestic product.
You may also be interested in...
NIH Sequester: Grants Down, But SBIR Program Less Impacted
Each institute within NIH has taken a slightly different approach to responding to the sequestration cuts, and, generally, the Small Business Innovation Research and Small Business Technology Transfer grant programs are subject to less significant reductions than traditional grants.
‘Unbalanced’ EU HTA Timelines Exacerbated By Rare Disease & Cancer Drugs
As it stands, drugmakers will have just 90 days to prepare their dossiers for EU-wide joint clinical assessments under the new Health Technology Assessment Regulation. Market access experts from EFPIA tell the Pink Sheet that this short deadline could delay patient access to complex medicines, such as innovative cancer drugs.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.